Utilizing the strength of our own Immune system to fight cancers is proving to be very successful approach.

Immuno-oncology (I/O) is emerging as one of the key areas in oncology drug discovery and development.

L2P Research® offers more than 30 syngeneic cancer models to be used in immune competent mice models.

We have fully validated tumor lines ready to be implanted for your next I/O study.

Our Syngeneic tumor models have been published in prestigious journals like “Cell” and “Cancer Research”.

For several of our models, we have growth curves available, and we continue to build our data with therapeutic antibodies like anti-CTLA-4, anti-PDL-1, and anti-PD-1.

Our I/O models include cancers specific to Colon, Brian, Lung, Skin, Liver, Pancreas, Kidney and ovaries.